Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Science|August 13, 2010
A defucosylated anti-CD317 antibody exhibited enhanced antibody-dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patientsTakahiro Ishiguro, Shigeto Kawai, Kiyoshi Habu, et al.
Oncology Reports|January 5, 2006
Antitumor activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma xenograft modelsShigeto Kawai, Yasushi Yoshimura, Shin-Ichiro Iida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24Steven B Rew, Karl Peggs, Irene Sanjuan, et al.
Biochemical and Biophysical Research Communications|November 24, 2004
2D7 diabody bound to the alpha2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cellsNaoki Kimura, Shigeto Kawai, Yasuko Kinoshita, et al.
Scientific Reports|April 3, 2025
Robust and reproducible human intestinal organoid-derived monolayer model for analyzing drug absorptionKai Tanaka, Tatsuki Mochizuki, Shogo Baba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanomaYumiko Azuma, Yuji Ishikawa, Shigeto Kawai, et al.
Cancer Research|February 7, 2007
A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environmentEtsuko Sekimoto, Shuji Ozaki, Takashi Ohshima, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 31, 2020
Continuous formation of small clusters with LGR5-positive cells contributes to tumor growth in a colorectal cancer xenograft modelMasaki Yamazaki, Atsuhiko Kato, Eiji Oki, et al.
Plos One|January 4, 2014
Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitorsTakeshi Harada, Shuji Ozaki, Asuka Oda, et al.
International Journal of Clinical Oncology|January 20, 2026
Molecular analysis of tumor recurrence using established cancer stem cell-line and drug discoveryKiyotaka Nakano, Eiji Oki, Masaki Yamazaki, et al.
Pageof 3